XML 49 R38.htm IDEA: XBRL DOCUMENT v3.22.2.2
Commitments and Contingencies (Tables)
9 Months Ended
Sep. 30, 2022
Commitments And Contingencies Disclosure [Abstract]  
Schedule of Lease Term and Discount Rate

Financing liability information is as follows:

 

 

 

September 30, 2022

 

 

December 31, 2021

 

Weighted average remaining lease term (in years)

 

 

19.1

 

 

 

19.8

 

Weighted average discount rate

 

 

9.0

%

 

 

9.0

%

 

 

September 30, 2022

 

 

December 31, 2021

 

Operating lease right-of-use assets(1)

 

$

7,046

 

 

$

2,284

 

 

 

 

 

 

 

 

 

 

Weighted average remaining lease term (in years)

 

 

4.9

 

 

 

2.6

 

Weighted average discount rate

 

 

7.3

%

 

 

7.3

%

__________________________________________________

_________________________

(1)

Operating right-of-use assets related to vehicles, offices and the manufacturing facility are included in other assets in the condensed consolidated balance sheets.

Summary of Lease Information

 

 

 

 

Three Months Ended

September 30,

 

 

Nine Months Ended

September 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Interest expense on financing liability

 

$

2,466

 

 

$

 

 

$

7,280

 

 

$

 

Lease information is as follows (in thousands):

 

 

 

Three Months Ended

September 30,

 

 

Nine Months Ended

September 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Operating lease costs

 

$

408

 

 

$

323

 

 

$

1,037

 

 

$

1,008

 

Variable lease costs

 

 

76

 

 

 

128

 

 

 

235

 

 

 

359

 

Cash paid

 

 

441

 

 

 

451

 

 

 

1,328

 

 

 

1,367

 

 

 

Summary of Financing Liability Payments

 

Financing liability payments were as follows (in thousands):

 

 

 

September 30, 2022

 

 

December 31, 2021

 

2022

 

$

2,410

 

 

$

6,373

 

2023

 

 

9,774

 

 

 

9,778

 

2024

 

 

10,018

 

 

 

10,023

 

2025

 

 

10,269

 

 

 

10,274

 

2026

 

 

10,533

 

 

 

10,539

 

Thereafter

 

 

199,302

 

 

 

199,091

 

Total

 

 

242,306

 

 

 

246,078

 

Interest expense

 

 

(135,361

)

 

 

(142,485

)

Debt issuance costs

 

 

(2,936

)

 

 

(3,091

)

Total financing liability

 

$

104,009

 

 

$

100,502

 

 

Remaining Purchase Requirements

In May 2021, the Company and Amphastar amended the Insulin Supply Agreement to extend the term and restructure the annual purchase commitments. In connection with the amendment, the Company agreed to pay $2.0 million of amendment fees, which were recognized in cost of goods sold for the nine months ended September 30, 2021. The remaining purchase commitments as of September 30, 2022 were as follows:

 

 

September 30, 2022

2022

1.3 million

2023

8.8 million

2024

14.6 million

2025

15.5 million

2026

19.4 million

2027

9.2 million

 

Schedule of Future Minimum Office And Vehicle Lease Payments

Future minimum office and vehicle lease payments as of September 30, 2022 and December 31, 2021, are as follows (in thousands):

 

 

 

September 30, 2022

 

 

December 31, 2021

 

2022

 

$

483

 

 

$

1,444

 

2023

 

 

1,368

 

 

 

497

 

2024

 

 

1,892

 

 

 

409

 

2025

 

 

1,861

 

 

 

311

 

2026

 

 

1,140

 

 

 

 

Thereafter

 

 

1,715

 

 

 

 

Total

 

$

8,459

 

 

$

2,661